Spinal Cord Diseases  >>  Recombivax HB (hepatitis B vaccine recombinant)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Recombivax HB (hepatitis B vaccine recombinant) / Merck (MSD)
NCT02040636: Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis

Completed
2
277
Canada
Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV, TdcP-IPV, Hepatitis B vaccine, Recombivax HB®
Sanofi Pasteur, a Sanofi Company
Pertussis, Tetanus, Diphtheria, Poliomyelitis, Hepatitis B
05/00
05/00

Download Options